1. Gottlieb, S. Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. fda.gov, https://go.nature.com/31Orwue (January 2019).
2. Dodson, B. P. & Levine, A. D. BMC Biotechnol. 15, 70 (2015).
3. Levine, B. L., Miskin, J., Wonnacott, K. & Keir, C. Mol. Ther. Methods Clin. Dev. 4, 92–101 (2017).
4. National Cell Manufacturing Consortium. Achieving Large-Scale, Cost-Effective, Reproducible Manufacturing of High-Quality Cells: A Technology Roadmap to 2025 (Nexight Group, 2016); https://cellmanufacturingusa.org/sites/default/files/NCMC_Roadmap_021816_high_res-2.pdf
5. Sullivan, J. As companies dump money into manufacturing, where will they find the trained workers to man the lines? Endpoints News, https://go.nature.com/3FoeEsu (June 2021).